US Supreme Court pauses $6bn Sackler family opioid settlement for review

The Supreme Court of the United States has placed a hold on a legal settlement approved by a federal appeals court that would have seen Purdue Pharma, the company most blamed for the US opioid epidemic, pay $7.2bn to states, cities, native tribes, and individuals harmed by its marketing practices, including $6bn from Purdue’s former owners, the Sackler family.The settlement, announced in May after the Sacklers increased their offer from $4.3bn, was accepted by all the US plaintiffs, effectively overruling objections from a smaller number of Canadian plaintiffs.1 But it was another party to the case, the US Trustee, a Department of Justice official responsible for the integrity of the bankruptcy system, who has now persuaded the country’s top court to re-examine the constitutionality of the deal.A novel feature of the settlement was that while only Purdue had declared bankruptcy, protections against future civil suits, except those brought by the…
Read Original Article: US Supreme Court pauses $6bn Sackler family opioid settlement for review »